2010
DOI: 10.1016/j.ejphar.2009.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

12
68
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 125 publications
(84 citation statements)
references
References 46 publications
12
68
0
Order By: Relevance
“…In previous research, it was demonstrated that Neferine had antiinflammation, antioxidation and anti-pulmonary fibrosis activities [4,14]. However, the mechanism is not clear.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In previous research, it was demonstrated that Neferine had antiinflammation, antioxidation and anti-pulmonary fibrosis activities [4,14]. However, the mechanism is not clear.…”
Section: Discussionmentioning
confidence: 99%
“…Chen et al demonstrated that Neferine had an antifibrotic effect on CCl 4 -induced hepatic fibrosis in mice because of the reduced expression of transforming growth factor-β1 (TGF-β1) in the liver [13]. In addtion, it was reported that Neferine has anti-fibrotic and anti-inflammatory effects on the amiodarone and bleomycininduced lung fibrosis model [4,14]. Although, the previous data represented anti-fibrotic activities of Neferine in pulmonary fibrosis, the protective mechanism of Neferine in pulmonary fibrosis is not known.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Elsewhere in that paper [180], they have elevated NF-B activity as part of their cycle. e drug bleomycin has been shown to initiate some cases of PAH [162,181]. It is known to increase several mechanisms involved in the NO/ONOO − cycle including stimulating poly (ADP-ribose) polymerase (PARP), oxidative stress, superoxide generation, in�ammatory cytokines, oxidative stress, partial uncoupling of the NOSs (which is presumably caused by BH4 depletion), mitochondrial dysfunction, and NF-B elevation [181][182][183][184][185].…”
Section: Principlementioning
confidence: 99%
“…e drug bleomycin has been shown to initiate some cases of PAH [162,181]. It is known to increase several mechanisms involved in the NO/ONOO − cycle including stimulating poly (ADP-ribose) polymerase (PARP), oxidative stress, superoxide generation, in�ammatory cytokines, oxidative stress, partial uncoupling of the NOSs (which is presumably caused by BH4 depletion), mitochondrial dysfunction, and NF-B elevation [181][182][183][184][185]. Superoxide is speci�cally implicated in having a causal role in bleomycininitiated PAH because overexpression of superoxide dismutase in a mouse model lessens subsequent pulmonary hypertension, �brosis, and vascular remodeling following bleomycin treatment [185].…”
Section: Principlementioning
confidence: 99%